kabutan

PeptiDream Inc.(4587) Summary

4587
TSE Prime
PeptiDream Inc.
1,562.0
JPY
+11.0
(+0.71%)
Dec 5, 11:30 am JST
10.07
USD
Dec 4, 9:30 pm EST
Result
PTS
outside of trading hours
1,554.8
Dec 5, 11:05 am JST
Summary Chart Historical News Financial Result
PER
PBR
3.84
Yield
ー%
Margin Trading Ratio
8.94
Stock Price
Dec 5, 2025
Opening Dec 5, 9:00 am
1,541.0 JPY 9.93 USD
Previous Close Dec 4
1,551.0 JPY 9.98 USD
High Dec 5, 10:32 am
1,583.0 JPY 10.21 USD
Low Dec 5, 9:00 am
1,532.0 JPY 9.87 USD
Volume
408,600
Trading Value
0.64B JPY 4.11M USD
VWAP
1560.85 JPY 10.07 USD
Minimum Trading Value
156,200 JPY 1,007 USD
Market Cap
0.20T JPY 1.31B USD
Number of Trades
1,870
Liquidity & Number of Trades
As of Dec 5, 2025
Liquidity
High
1-Year Average
2,757
1-Year High Feb 14, 2025
14,693
Margin Trading
Date Short Interest Long Margin Positions Ratio
Nov 28, 2025 115,600 1,509,800 13.06
Nov 21, 2025 92,700 1,576,600 17.01
Nov 14, 2025 88,400 1,692,500 19.15
Nov 7, 2025 82,400 1,791,900 21.75
Oct 31, 2025 92,800 1,701,000 18.33
Company Profile
PeptiDream Inc. is a drug discovery venture company that collaborates with major pharmaceutical companies to develop peptide-based drugs. The company has also acquired a radiopharmaceutical business.
Sector
Pharmaceuticals
PeptiDream Inc. is a biotech venture originating from the University of Tokyo, focusing primarily on drug discovery and development using special peptides through its proprietary drug discovery platform system, PDPS. The company engages in collaborative drug research and development using PDPS, technology licensing, and strategic partnerships to expand its in-house pipeline. Through its subsidiary PDR Pharma, PeptiDream Inc. also operates in the radiopharmaceutical business, conducting research, development, manufacturing, and sales of diagnostic and therapeutic radiopharmaceuticals. The company concentrates on developing diagnostic agents for imaging cancer and abnormal brain accumulations, as well as therapeutic radiopharmaceuticals targeting unmet medical needs, particularly in the field of oncology. As a group, PeptiDream Inc. operates across a wide range of areas including research, development, manufacturing, and sales of pharmaceuticals and related products.